Purpose
|
Cilostazol is a medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease. It is manufactured by Otsuka Pharmaceutical Co. under the trade name Pletal. Although drugs similar to cilostazol have increased the risk of death in patients with congestive heart failure, studies of significant size have not addressed people without the disease.
|
Characteristics
|
Tradename: PLETAL Source of Compound: synthetic, OPC-13013 Target: PDE inhibitor Receptor: PDE3 Status: USAN, INN, BAN, JAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C20H27N5O2
|
Solubility
|
DMSO 74 mg/mL, Ethanol 6 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |